Univariate and multivariate analyses revealed that β2 microglobulin levels before chemotherapy and lesion length after chemotherapy were independent predictors of CR in patients with gastric DLBCL. The gene discussed is HLA-G; the disease is diffuse large B-cell lymphoma.